The LOEWE Center Frankfurt Cancer Institute (FCI) will continue to receive funding from the State of Hesse. Today, Minister of Science Timon Gremmels presented a grant of twelve million euros for the years 2026 and 2027 at the Georg-Speyer-Haus in Frankfurt. At the FCI, researchers from Goethe University Frankfurt, Georg-Speyer-Haus, Max Planck Institute for Heart and Lung Research, Paul Ehrlich Institute, and the German Red Cross Blood Donor Service/Institute for Transfusion Medicine and Immunohematology work together. The lead institution is Goethe University.
“With the Frankfurt Cancer Institute, the participating research institutions—supported by LOEWE—have created an internationally recognized, well-connected center for cancer research. We are very proud of that,” said Minister of Science Timon Gremmels. “Research at the interface between basic and applied science is unique in Germany in this form. By continuing to fund the LOEWE Center, we are reinforcing our goal of transitioning this consortium into joint federal-state funding. Since 2019, we have supported this effort with a total of 42 million euros.”
Prof. Michael Huth, Vice President for Technology Transfer at Goethe University, emphasized: “At the Frankfurt Cancer Institute under the leadership of Prof. Florian Greten, we are working closely with our non-university partners and industry to translate insights from excellent basic research directly into clinical trials for innovative cancer therapies. This close integration characterizes both Goethe University’s strategy and its formula for successful research that benefits society. This support will allow us to continue this important work.”
Cancer genes can now be fully decoded within just a few days. However, to predict how well a patient will respond to treatment, genetic data alone are not sufficient. It is also necessary to understand how mutations affect processes within the tumor cell and what impact they have on the surrounding tissue and the immune system. Investigating this complex interplay is the mission of the FCI.
At the LOEWE Center, integrative tumor medicine is practiced in its fullest sense—from clinical research to collaboration with pharmaceutical companies, all relevant aspects are taken into account. At the FCI, researchers from the participating institutions work together on translational cancer research that bridges the gap between the patient’s bedside and the laboratory. This means that research findings are immediately translated into medical care.
A research building funded by both federal and state resources, and additionally supported by a substantial donation from the German Cancer Aid, will ensure in the long term that researchers from the participating institutions can work even more closely together in shared laboratory spaces.
Source: Hessian Ministry of Science →
